Hassan Amiri - Emergency Department, Iran University of Medical Sciences, Tehran, Iran
Ali Bidari - Emergency Department, Iran University of Medical Sciences, Tehran, Iran
Samad Shams Vahdati - Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Nilofar Ghodrati - Department of Hematology Oncology, Alborz University of Medical Sciences, Karaj, Iran
Tayeb Ramim - Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran
Masoumeh Emamverdy - Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Objective: There are many communities at risk by a series of air pollution episodes. Tehran is one of the most polluted cities in the world. The presence of one or more air pollutants with a certain concentration in a particular period of time can cause several adverse effects on human and animals’ well-being that can cause much morbidity. There are several pollutants in the air but some of them can cause severe adverse effects on the lungs and air ways.Methods: In this retrospective cross-sectional study ۱۹۵۸ patients with exacerbation of chronic obstructive pulmonary disease (COPD) who were admitted in the emergency department (ED) of Rasol Akram hospital between March ۲۰۰۴ and March ۲۰۰۶ entered the study. Data such as number of admissions, air pollution particles (CO, SO۲, O۳, NO۲, PM۱۰) according to available documents were analyzed.Results: From ۱۹۵۸ patients who enrolled in this study, ۸۸۷ (۵۳.۵%) were male and ۷۷۱ (۴۶.۵%) were female. According to statistical analysis, we could observe a significant correlation between the concentration of Co, PM۱۰, So۲ with ED admission rate of COPD exacerbation (P: ۰.۰۳۱, ۰.۰۰۸, and ۰.۰۰۱ respectively). The effect of PM۱۰, So۲ and Co was more significant respectively in logistic regression on ED admission.Conclusion: There was significant correction between concentrations of air pollutants with number of ED admission for COPD exacerbation.

Air pollution, SO۲, No۲, CO, PM۱۰, O۳, COPD